Literature DB >> 29948033

Elevated Pulmonary Artery Pressure, Not Pulmonary Vascular Resistance, is an Independent Predictor of Short-Term Morbidity Following Bidirectional Cavopulmonary Connection.

Susanna Tran1,2, Patrick M Sullivan3,4, John Cleveland5,6, S Ram Kumar5,4,6, Cheryl Takao3,4.   

Abstract

Single ventricle palliation relies on the pulmonary vasculature accommodating non-pulsatile systemic venous return. Mean pulmonary artery pressure (MPAP) and indexed pulmonary vascular resistance (PVRi) are two measures that impact pulmonary blood flow following bidirectional cavopulmonary connection (BCPC). The purpose of the study was to determine which hemodynamic features are associated with adverse outcomes after BCPC. Pre-operative hemodynamic data and post-operative morbidity and mortality in 250 patients undergoing BCPC at a single center from 2008 to 2014 were reviewed. Patients were then separated into 5 physiologic states based on MPAP, PVRi, and degree of pulmonary to systemic blood flow (Qp:Qs). There were 9 (3.6%) deaths, and 49 patients (20%) sustained major morbidity. An ROC curve identified MPAP > 16 mmHg as an inflection point. Pre-BCPC sildenafil and oxygen use, ventricular dysfunction, and MPAP > 16 mmHg (OR 4.1 [95% CI 1.8-9.2]) were independently associated with morbidity. MPAP > 16 mmHg (OR 6.7 [95% CI 1.6-28]) and pre-BCPC oxygen use were associated with hospital mortality. PVRi was not associated with morbidity or mortality. Of the five physiologic states, patients with high MPAP, low PVRi, and low Qp:Qs fared the worst, with the highest risk of major morbidity (OR 8.6 [3.0-24.9]) and highest risk of mortality (OR 8.0 [1.5-41.3]) when compared to their reference groups (low MPAP, low PVRi). Elevated MPAP, need for pre-operative oxygen support, sildenafil use, and systemic ventricular systolic dysfunction predict morbidity following BCPC. Specifically, patients with elevated MPAP not due to elevated PVRi or pulmonary blood flow had the highest risk of morbidity and mortality.

Entities:  

Keywords:  Glenn procedure; Morbidity; Mortality; Risk factor

Mesh:

Substances:

Year:  2018        PMID: 29948033     DOI: 10.1007/s00246-018-1932-6

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  17 in total

1.  Factors influencing survival in patients after bidirectional Glenn shunt.

Authors:  Suchaya Silvilairat; Yupada Pongprot; Rekwan Sittiwangkul; Surin Woragidpoonpol; Suphachai Chuaratanaphong; Weerachai Nawarawong
Journal:  Asian Cardiovasc Thorac Ann       Date:  2008-10

2.  Indications and timing for the bidirectional Glenn shunt versus the fenestrated Fontan circulation.

Authors:  R A Jonas
Journal:  J Thorac Cardiovasc Surg       Date:  1994-09       Impact factor: 5.209

3.  Interstage attrition between bidirectional Glenn and Fontan palliation in children with hypoplastic left heart syndrome.

Authors:  Waldemar F Carlo; Kathleen E Carberry; Jeffrey S Heinle; David L Morales; E Dean McKenzie; Charles D Fraser; David P Nelson
Journal:  J Thorac Cardiovasc Surg       Date:  2011-06-25       Impact factor: 5.209

4.  Risk factors for failed staged palliation after bidirectional Glenn in infants who have undergone stage one palliation.

Authors:  Kevin G Friedman; Joshua W Salvin; David Wypij; Yared Gurmu; Emile A Bacha; David W Brown; Peter C Laussen; Mark A Scheurer
Journal:  Eur J Cardiothorac Surg       Date:  2011-03-05       Impact factor: 4.191

5.  Risk factor analysis for second-stage palliation of single ventricle anatomy.

Authors:  Timothy M Lee; Ranjit Aiyagari; Jennifer C Hirsch; Richard G Ohye; Edward L Bove; Eric J Devaney
Journal:  Ann Thorac Surg       Date:  2011-12-23       Impact factor: 4.330

6.  Usefulness of the bidirectional Glenn procedure as staged reconstruction for the functional single ventricle.

Authors:  A K Pridjian; A M Mendelsohn; F M Lupinetti; R H Beekman; M Dick; G Serwer; E L Bove
Journal:  Am J Cardiol       Date:  1993-04-15       Impact factor: 2.778

7.  The role of cava-pulmonary (Glenn) anastomosis in the palliative treatment of congenital heart disease.

Authors:  D di Carlo; W G Williams; R M Freedom; G A Trusler; R D Rowe
Journal:  J Thorac Cardiovasc Surg       Date:  1982-03       Impact factor: 5.209

8.  Outcomes after bidirectional Glenn operation: Blalock-Taussig shunt versus right ventricle-to-pulmonary artery conduit.

Authors:  Lillian Lai; Peter C Laussen; Clifford L Cua; David L Wessel; John M Costello; Pedro J del Nido; John E Mayer; Ravi R Thiagarajan
Journal:  Ann Thorac Surg       Date:  2007-05       Impact factor: 4.330

9.  The bidirectional Glenn operation: a risk factor analysis for morbidity and mortality.

Authors:  Brian E Kogon; Courtney Plattner; Traci Leong; Janet Simsic; Paul M Kirshbom; Kirk R Kanter
Journal:  J Thorac Cardiovasc Surg       Date:  2008-07-17       Impact factor: 5.209

10.  Factors influencing survival in patients undergoing the bidirectional Glenn anastomosis.

Authors:  J C Alejos; R G Williams; J M Jarmakani; A J Galindo; J B Isabel-Jones; D Drinkwater; H Laks; S Kaplan
Journal:  Am J Cardiol       Date:  1995-05-15       Impact factor: 2.778

View more
  3 in total

1.  Factors influencing length of intensive care unit stay following a bidirectional cavopulmonary shunt.

Authors:  Takashi Kido; Masamichi Ono; Lisa Anderl; Melchior Burri; Martina Strbad; Gunter Balling; Julie Cleuziou; Alfred Hager; Peter Ewert; Jürgen Hörer
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-06-28

2.  Increased Circulating Endothelin 1 Is Associated With Postoperative Hypoxemia in Infants With Single-Ventricle Heart Disease Undergoing Superior Cavopulmonary Anastomosis.

Authors:  Benjamin S Frank; Ludmila Khailova; Lori Silveira; Max B Mitchell; Gareth J Morgan; Michael V DiMaria; Jesse A Davidson
Journal:  J Am Heart Assoc       Date:  2022-03-04       Impact factor: 6.106

3.  Risk Factors for Prolonged Mechanical Ventilation After Pulmonary Endarterectomy: 7 Years' Experience From an Experienced Hospital in China.

Authors:  Congya Zhang; Lijing Yang; Sheng Shi; Zhongrong Fang; Jun Li; Guyan Wang
Journal:  Front Surg       Date:  2021-06-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.